GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » PS Ratio

WuXi XDC Cayman (HKSE:02268) PS Ratio : 12.10 (As of Dec. 15, 2024)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, WuXi XDC Cayman's share price is HK$30.75. WuXi XDC Cayman's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$2.54. Hence, WuXi XDC Cayman's PS Ratio for today is 12.10.

The historical rank and industry rank for WuXi XDC Cayman's PS Ratio or its related term are showing as below:

HKSE:02268' s PS Ratio Range Over the Past 10 Years
Min: 6.73   Med: 9.3   Max: 35.57
Current: 12.1

During the past 4 years, WuXi XDC Cayman's highest PS Ratio was 35.57. The lowest was 6.73. And the median was 9.30.

HKSE:02268's PS Ratio is ranked worse than
87.85% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.995 vs HKSE:02268: 12.10

WuXi XDC Cayman's Revenue per Sharefor the six months ended in Jun. 2024 was HK$1.39. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$2.54.

During the past 12 months, the average Revenue per Share Growth Rate of WuXi XDC Cayman was 64.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 181.10% per year.

During the past 4 years, WuXi XDC Cayman's highest 3-Year average Revenue per Share Growth Rate was 181.10% per year. The lowest was 181.10% per year. And the median was 181.10% per year.

Back to Basics: PS Ratio


WuXi XDC Cayman PS Ratio Historical Data

The historical data trend for WuXi XDC Cayman's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman PS Ratio Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23
PS Ratio
- - - 14.85

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PS Ratio Get a 7-Day Free Trial - - - 14.85 -

Competitive Comparison of WuXi XDC Cayman's PS Ratio

For the Diagnostics & Research subindustry, WuXi XDC Cayman's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WuXi XDC Cayman's PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's PS Ratio distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's PS Ratio falls into.



WuXi XDC Cayman PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

WuXi XDC Cayman's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=30.75/2.541
=12.10

WuXi XDC Cayman's Share Price of today is HK$30.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$2.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


WuXi XDC Cayman  (HKSE:02268) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


WuXi XDC Cayman PS Ratio Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


WuXi XDC Cayman Business Description

Comparable Companies
Traded in Other Exchanges
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Executives
Wuxi Biologics (cayman) Inc. 2101 Beneficial owner
Wuxi Apptec Co., Ltd.
Shang Hai He Quan Yao Ye Gu Fen You Xian Gong Si
He Quan Yao Ye Xiang Gang Tou Zi You Xian Gong Si
Shang Hai Yao Ming Kang De Xin Yao Kai Fa You Xian Gong Si

WuXi XDC Cayman Headlines

No Headlines